Rx Medicare

For the first time, a combination of aspirin and the anti-platelet drug dipyridamole has been shown to significantly reduce blockages and extend the useful life of new artery-vein access grafts used for hemodialysis, according to a study by the Dialysis Access Consortium (DAC).

Read More…

Related Posts

• Statement By Medicare Rights Center President Joe Baker On Reduced State “Clawback” Payments For Medicare Drug Coverage
• Toward A Less Expensive Version Of The Anti-flu Drug Tamiflu
• Painkiller undermines aspirin’s anti-clotting action
• NanoViricides, Inc. To Present Anti-Influenza Drug Candidate FluCide™ Studies At The Influenza Congress 2009
• Cardiovascular Risk: Aspirin Works For Primary Prevention In Moderate And High Risk Diabetics
• Anti Flu Drug Did Well In Final Stage Trials Says Japan’s Daiichi Sankyo
• Link Between Migraines And Reduced Breast Cancer Risk Confirmed
• Funxional Successfully Completes Initial Clinical Trial Of FX125L, An Anti-Inflammatory Drug With A Novel Mechanism Of Action
• Follow-Up Study Confirms Link Between Migraines And Reduced Breast Cancer Risk
• Link Between Migraines And Reduced Breast Cancer Risk Confirmed In Follow-up Study
• Valproate Anti-Epilepsy Drug In Pregnancy Linked To Lower IQ In Children
• Aspirin Recommendation Underscores Need For Physicians And Patients To Discuss Benefits And Risk
• Drug Resistant Influenza A Virus Potentially Serious To High-Risk Patients
• Shift workers at more risk for irritable bowel syndrome, study finds
• Internal medicine residency training for unhealthy alcohol and other drug use: recommendations for curriculum design

Tags: access, anti, aspirin, clotting, combination, dialysis, drug, failure, reduced, risk

This entry was posted on Tuesday, May 26th, 2009 at 2:05 pm and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.